Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2025-12-26 @ 12:27 AM
NCT ID:
NCT04396860
Group ID:
EG001
Title:
Arm II (Radiation Therapy, Ipilimumab, Nivolumab)
Description:
Patients undergo radiation therapy for 5 days per week (Monday-Friday) for a total of 30 fractions over 6 weeks. Starting on the first day of radiation, patients also receive ipilimumab IV over 90 minutes Q4W for 4 doses and nivolumab IV over 30 minutes every 2 weeks until disease progression. Patients also undergo contrast-enhanced brain MRI throughout the trial.
Deaths Number Affected:
37
Deaths Number At Risk:
None
Serious Number Affected:
45
Serious Number At Risk:
78
Other Number Affected:
70
Other Number At Risk:
78
Study:
NCT04396860
Results Section:
NCT04396860
Adverse Events Module:
NCT04396860